VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 14 filers reported holding VIRPAX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $13 | +30.0% | 16,070 | -2.4% | 0.00% | – |
Q4 2022 | $10 | -100.0% | 16,470 | -2.1% | 0.00% | – |
Q3 2022 | $20,000 | -28.6% | 16,820 | 0.0% | 0.00% | – |
Q2 2022 | $28,000 | -26.3% | 16,820 | -2.0% | 0.00% | – |
Q1 2022 | $38,000 | -37.7% | 17,170 | -3.4% | 0.00% | – |
Q4 2021 | $61,000 | -34.4% | 17,770 | -8.5% | 0.00% | – |
Q3 2021 | $93,000 | – | 19,420 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,059,383 | $1,780,000 | 1.21% |
Quantum Private Wealth, LLC | 10,000 | $16,000 | 0.01% |
Warberg Asset Management LLC | 19,500 | $33,000 | 0.01% |
OSAIC HOLDINGS, INC. | 160 | $0 | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 100,875 | $169,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 57 | $0 | 0.00% |
NORTHERN TRUST CORP | 15,221 | $26,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 66,223 | $111,000 | 0.00% |
MORGAN STANLEY | 18,016 | $30,000 | 0.00% |